trending Market Intelligence /marketintelligence/en/news-insights/trending/wdomxjsdgv8nvdkskbpk4a2 content esgSubNav
In This List

Catalent board member resigns; 3 board members added

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Catalent board member resigns; 3 board members added

New Jersey-based Catalent Inc. said James Quella retired as a board member after nine years of service.

Concurrently, the pharmaceuticals company added Rosemary Crane, John Greisch and Christa Kreuzburg to its board

Crane serves as a board member for Edge Therapeutics Inc., Teva Pharmaceutical Industries Ltd. and Zealand Pharma A/S. She retired in 2014 from MELA Sciences Inc., where she served as president and CEO.

Greisch is set to retire later in 2018 as the president and CEO of Hill-Rom Holdings Inc.

Kreuzburg has been a consultant in the healthcare sector after retiring from Bayer AG in 2009. She is a board member of Tecan Trading AG.